Xiaoqin Li

机构：Fuzhou Pulmonary Hospital of Fujian, Fujian Provincial Hospital · ORCID：0000-0003-3762-9817

发表论文 119 篇 · 总被引 1925 次 · h-index 23

代表论文

• Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review (2025 · Frontiers in Immunology · 被引 15)
• m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy (2023 · Frontiers in Immunology · 被引 14)
• Summary of the best evidence for the prevention of nasal injury in preterm infants with nasal noninvasive ventilation (2024 · Translational Pediatrics · 被引 9)
• Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study (2025 · Frontiers in Pharmacology · 被引 8)
• A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer (2024 · Journal of Translational Medicine · 被引 8)
• An oncogene regulating chromatin favors response to immunotherapy (2024 · OncoImmunology · 被引 6)